The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Onyx's 2012 oncology sales performance.
Onyx Health has announced three new appointments, marking the latest phase in the agency’s expansion. ... Commenting on the new hires, Trevor Pill, managing director, said: “We’re delighted to have Laura, Katy and Lewis join the talented Onyx
Meanwhile, HeartScan, an echocardiography and sports screening company, has appointed Onyx health to deliver a customer insights strategy. ... Dr Antionette Kenny, director at HeartScan, said: “Onyx Health has extensive experience in health screening
Will develop a marketing strategy for the UK-based firm. Marketing communications agency, Onyx Health has been appointed by Newcastle upon Tyne, UK-based OLM Diagnostics to develop and implement a ... Frazer Thompson, operations director and OLM
The new drug gives patients an alternative to injectable proteasome inhibitors such as Takeda's own market-leading Velcade (bortezomib) as well as Amgen and Onyx' rival therapy Kyprolis (carfilzomib), which
That performance has disappointed some analysts however who have been looking for a bigger return on the $10.4bn paid by Amgen for Kyprolis' developer Onyx in 2013 after the drug
No results were found
Origins creates and delivers patient focused strategy, insights, data and solutions, which guides pharma and biotech companies to improve value...